4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Ajanta Pharma Limited (AJANTPHARM) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 10,421 employees. Its market capitalization is roughly ₹445 billion. In the fiscal year ended 2026-03-31, AJANTPHARM reported ₹54.1B in revenue and ₹10.6B in net income.
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹54.1B | ₹45.9B | ₹41.6B | ₹37.1B | — |
| Gross Profit | ₹41.6B | ₹34.6B | ₹30.5B | ₹25.9B | — |
| Operating Income (EBIT) | ₹13.3B | ₹11.3B | ₹10.5B | ₹6.8B | — |
| Net Income | ₹10.6B | ₹9.2B | ₹8.2B | ₹5.9B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹16.3B | ₹14.2B | ₹13.7B | ₹13.0B | ₹11.7B | — |
| Gross Profit | ₹13.0B | ₹11.2B | ₹10.9B | ₹10.3B | ₹8.9B | — |
| Operating Income (EBIT) | ₹8.7B | ₹7.3B | ₹7.1B | ₹6.8B | ₹5.7B | — |
| Net Income | ₹3.3B | ₹2.7B | ₹2.7B | ₹2.6B | ₹2.3B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹3.5B) | (₹3.5B) | (₹6.4B) | (₹897M) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹61.5B | ₹50.1B | ₹46.4B | ₹46.8B | — |
| Total Liabilities | ₹16.3B | ₹12.2B | ₹10.7B | ₹12.9B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AJANTPHARM viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms